Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXJ6LF
|
||||
| Drug Name |
2-cyano-4-(2,2-dimethyl-propylamino)-pyrimidine-5-carboxylic acid [2-(3-methoxy-phenyl)-ethyl]-amide
|
||||
| Synonyms |
CHEMBL221707
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H25N5O2
|
||||
| Canonical SMILES |
COc1cccc(CCNC(=O)c2cnc(nc2NCC(C)(C)C)C#N)c1
|
||||
| InChI |
InChI=1S/C20H25N5O2/c1-20(2,3)13-24-18-16(12-23-17(11-21)25-18)19(26)22-9-8-14-6-5-7-15(10-14)27-4/h5-7,10,12H,8-9,13H2,1-4H3,(H,22,26)(H,23,24,25)
|
||||
| InChIKey |
GJHYTSFTSOMLTG-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.